A personalized DVH prediction model for HDR brachytherapy in cervical cancer treatment

被引:5
|
作者
Li, Zhen [1 ]
Chen, Kehui [2 ]
Yang, Zhenyu [3 ]
Zhu, Qingyuan [1 ]
Yang, Xiaojing [1 ]
Li, Zhaobin [1 ]
Fu, Jie [1 ]
机构
[1] Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Shanghai, Peoples R China
[3] Duke Univ, Durham, NC USA
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
machine learning; brachytherapy; cervical cancer; dose prediction; radiation oncology; RADIATION-THERAPY; DOSE PREDICTION; QUALITY; TOOL;
D O I
10.3389/fonc.2022.967436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeAlthough the knowledge-based dose-volume histogram (DVH) prediction has been largely researched and applied in External Beam Radiation Therapy, it is still less investigated in the domain of brachytherapy. The purpose of this study is to develop a reliable DVH prediction method for high-dose-rate brachytherapy plans. MethodA DVH prediction workflow combining kernel density estimation (KDE), k-nearest neighbor (kNN), and principal component analysis (PCA) was proposed. PCA and kNN were first employed together to select similar patients based on principal component directions. 79 cervical cancer patients with different applicators inserted was included in this study. The KDE model was built based on the relationship between distance-to-target (DTH) and the dose in selected cases, which can be subsequently used to estimate the dose probability distribution in the validation set. Model performance of bladder and rectum was quantified by |Delta D-2cc|, |Delta D-1cc|, |Delta D-0.1cc|, |Delta D-max|, and |Delta D-mean| in the form of mean and standard deviation. The model performance between KDE only and the combination of kNN, PCA, and KDE was compared. Result20, 30 patients were selected for rectum and bladder based on KNN and PCA, respectively. The absolute residual between the actual plans and the predicted plans were 0.38 +/- 0.29, 0.4 +/- 0.32, 0.43 +/- 0.36, 0.97 +/- 0.66, and 0.13 +/- 0.99 for |Delta D-2cc|, |Delta D-1cc|, |Delta D-0.1cc|, |Delta D-max|, and |Delta D-mean| in the bladder, respectively. For rectum, the corresponding results were 0.34 +/- 0.27, 0.38 +/- 0.33, 0.63 +/- 0.57, 1.41 +/- 0.99 and 0.23 +/- 0.17, respectively. The combination of kNN, PCA, and KDE showed a significantly better prediction performance than KDE only, with an improvement of 30.3% for the bladder and 33.3% for the rectum. ConclusionIn this study, a knowledge-based machine learning model was proposed and verified to accurately predict the DVH for new patients. This model is proved to be effective in our testing group in the workflow of HDR brachytherapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Deep-learning based Physician's Preference Prediction For HDR Brachytherapy Of Cervical Cancer
    Gonzalez, Y.
    Shen, C.
    Wang, C.
    Albuquerque, K.
    Jia, X.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1094 - S1095
  • [22] Investigation of the Dosimetric Impact of Tandem Loading in the Treatment of Cervical Cancer for HDR Brachytherapy Procedures
    Esquivel, C.
    Patton, L.
    Nelson, K.
    Lin, B.
    MEDICAL PHYSICS, 2014, 41 (06) : 369 - 369
  • [23] CT-BASED INTERSTITIAL HDR BRACHYTHERAPY FOR GYNAECOLOGIC CANCER : CLINICAL OUTCOMES AND DVH PARAMETERS
    Thibault, I.
    Lavallee, M. C.
    Laflamme, N.
    Vigneault, E.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S210 - S210
  • [24] HDR brachytherapy as monotherapy in the treatment of prostate cancer
    Komina, Oxana
    Seitz-Kaestner, Christine
    Pajer, Thomas
    Kohl, Bettina
    Hummel, Johann
    Knocke-Abulesz, Tomas-Hendrik
    Nechvile, Elisabeth
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S402 - S403
  • [25] HDR brachytherapy in the treatment of anal canal cancer
    Seewald, D.
    Track, Chr
    Hammer, J.
    Zoidl, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 193 - 193
  • [26] The dosimetric impact of interstitial needles in HDR brachytherapy for cervical cancer
    Otter, S.
    Coates, A.
    Franklin, A.
    Brennan, C.
    Cunningham, M.
    Stewart, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127
  • [27] Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy
    Lin, Alexander J.
    Samson, Pamela
    Zoberi, Jacqueline
    Garcia-Ramirez, Jose
    Williamson, Jeffrey F.
    Markovina, Stephanie
    Schwarz, Julie
    Grigsby, Perry W.
    BRACHYTHERAPY, 2019, 18 (03) : 353 - 360
  • [28] Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer
    Someya, Masanori
    Hasegawa, Tomokazu
    Tsuchiya, Takaaki
    Kitagawa, Mio
    Gocho, Toshio
    Fukushima, Yuuki
    Hori, Masakazu
    Miura, Katsutoshi
    Takada, Yu
    Nakata, Kensei
    Sakata, Koh-ichi
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (02) : 265 - 274
  • [29] Concurrent Chemoradiation for Cervical Cancer: Comparison of LDR and HDR Brachytherapy
    Lin, Alexander J.
    Samson, Pamela
    Zoberi, Jacqueline
    Garcia-Ramirez, Jose
    Williamson, Jeffrey
    Markovina, Stephanie
    Schwarz, Julie
    Grigsby, Perry
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E18 - E19
  • [30] HDR brachytherapy (HDR-BT) as a curative treatment in lung cancer
    Hennequin, C.
    Tredaniel, J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S182 - S182